Qingfu Xu

1.5k citations
58 papers · 1.2k indexed · h-index 23
Topics
Pneumonia and Respiratory Infections (23 papers)Respiratory viral infections research (19 papers)Bacterial Infections and Vaccines (16 papers)

In The Last Decade

Qingfu Xu

55 papers receiving 1.2k citations

Peers

Qingfu Xu
Comparison fields: 5 of 79
  • Epidemiology 563
  • Molecular Biology 430
  • Microbiology 293
  • Otorhinolaryngology 144
  • Cancer Research 135
Replace М. М. Шмаров with:
М. М. Шмаров Russia
Lisa A. Spencer United States
Adriana Contreras‐Paredes Mexico
Karl R. VanDerMeid United States
Zohreh Naghashfar United States
Abdelali Filali‐Mouhim Canada
Joseph G. Skeate United States
Barbara Marchetti United Kingdom
S Yasumoto Japan
Qingfu Xu relative to М. М. Шмаров Russia М. М. Шмаров's profile →
Citations per field
00.5×10×20×28.8×
М. М. Шмаров · 1×
Citations per year

Countries citing papers authored by Qingfu Xu

Since Specialization
Citations

This map shows the geographic impact of Qingfu Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfu Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfu Xu more than expected).

Fields of papers citing papers by Qingfu Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingfu Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfu Xu. The network helps show where Qingfu Xu may publish in the future.

Co-authorship network of co-authors of Qingfu Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingfu Xu. A scholar is included among the top collaborators of Qingfu Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingfu Xu. Qingfu Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 14
4 9
5 33
6 28
7 9
8 19
9 8
10 17
11 64
12 30
13 27
14 18
15 12
16 29
17 6
18
Effects of Somatostatin Genetic-engineering Vaccine on some Metabolites and Hormones in Sheep Peripheral Blood
1
19 14
20 4

About Qingfu Xu

Qingfu Xu is a scholar working on Microbiology, Otorhinolaryngology and Epidemiology, having authored 58 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (23 papers), Respiratory viral infections research (19 papers) and Bacterial Infections and Vaccines (16 papers). The work is most often cited by research in Microbiology (293 citations), Otorhinolaryngology (144 citations) and Epidemiology (563 citations). Qingfu Xu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Michael E. Pichichero, Janet R. Casey, Mingtao Zeng, M. Nadeem Khan, Ravinder Kaur, Shengqing Lv, David Verhoeven, Guo‐Hao Huang, Lei Yi and Yugang Jiang. Their work appears in journals such as Biochemistry, Cancer Research and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026